CannaPharmaRX, Inc.
CPMD · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $5,065 | $525 | $2,110 | $967 |
| - Cash | $2 | $1 | $2 | $28 |
| + Debt | $14,060 | $12,935 | $14,525 | $9,019 |
| Enterprise Value | $19,123 | $13,460 | $16,633 | $9,959 |
| Revenue | $820 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$2,935 | -$66 | -$295 | -$14 |
| % Margin | -357.9% | – | – | – |
| EBITDA | -$7,641 | -$1,447 | -$4,914 | -$2,614 |
| % Margin | -931.7% | – | – | – |
| Net Income | -$9,906 | $3,688 | -$8,531 | -$8,832 |
| % Margin | -1,207.8% | – | – | – |
| EPS Diluted | -0.016 | 0.012 | -0.04 | -0.12 |
| % Growth | -232.8% | 129.5% | 66.3% | – |
| Operating Cash Flow | -$1,697 | -$2,274 | -$1,448 | -$2,415 |
| Capital Expenditures | $0 | -$81 | -$116 | -$6 |
| Free Cash Flow | -$1,697 | -$2,355 | -$1,564 | -$2,421 |